 | Up a level |
Dave, Maneesh; Dev, Atul; Somoza, Rodrigo A; Zhao, Nan; Viswanath, Satish; Mina, Pooja Rani; Chirra, Prathyush; Obmann, Verena Carola; Mahabeleshwar, Ganapati H; Menghini, Paola; Durbin-Johnson, Blythe; Nolta, Jan; Soto, Christopher; Osme, Abdullah; Khuat, Lam T; Murphy, William J; Caplan, Arnold I; Cominelli, Fabio (2024). MSCs mediate long-term efficacy in a Crohn's disease model by sustained anti-inflammatory macrophage programming via efferocytosis. npj Regenerative Medicine, 9(1), p. 6. Nature Publishing Group 10.1038/s41536-024-00347-1
Dave, Maneesh; Dev, Atul; Somoza, Rodrigo A; Zhao, Nan; Viswanath, Satish; Mina, Pooja Rani; Chirra, Prathyush; Obmann, Verena Carola; Mahabeleshwar, Ganapati H; Menghini, Paola; Johnson, Blythe Durbin; Nolta, Jan; Soto, Christopher; Osme, Abdullah; Khuat, Lam T; Murphy, William; Caplan, Arnold I; Cominelli, Fabio (24 May 2023). Mesenchymal stem cells ameliorate inflammation in an experimental model of Crohn's disease via the mesentery. (bioRxiv). Cold Spring Harbor Laboratory 10.1101/2023.05.22.541829
